Fiber Supplements May Ease Arthritis Pain, Study Finds

Researchers at the University of Nottingham ran a clinical trial testing whether a daily fiber supplement could do more than move food through the gut. According to a report by the New York Post, the trial found that participants with osteoarthritis who took the supplement reported less pain, improved muscle strength and reduced sensitivity to pain compared with those who did not, the New York Post reported.

The finding reframes a supplement most people associate with regularity as a possible tool against a joint disease that affects movement, not digestion, and it arrives as patients and clinicians look for non-pharmaceutical ways to manage chronic pain.

What did the Nottingham trial actually measure?

The clinical trial tracked osteoarthritis patients given daily fiber supplementation and compared outcomes across pain levels, muscle strength and pain sensitivity, according to the Post's account of the Nottingham research. The paper does not break out exact percentage improvements or participant counts beyond describing the trial as having found benefits across those three measures. What is documented is the direction of the result: patients on fiber reported less pain and performed better on muscle strength measures than counterparts who skipped the supplement.

How might fiber affect pain, not just digestion?

The mechanism researchers pointed to involves glucagon-like peptide-1, or GLP-1, a hormone familiar to most readers now from diabetes and weight-loss drugs. The Nottingham researchers found that participants who took fiber had higher levels of GLP-1, which the Post describes as a hormone that "helps regulate blood sugar and appetite and has also been linked to pain regulation and muscle health." That dual role — appetite and pain — is the thread connecting a gut supplement to joint outcomes: if fiber intake nudges GLP-1 higher, and GLP-1 has a documented link to pain regulation, then a supplement aisle staple could be doing quiet work well outside the digestive tract.

The study does not claim fiber cures arthritis or replaces standard treatment, and the Post's writeup frames the result as a correlation worth further study rather than a settled mechanism.

What fiber products are people already using?

Fiber supplements are widely available and cheap relative to many wellness products, which is part of why the finding travels fast. The Post highlighted Physician's CHOICE Fiber Gummies for GLP-1 Support as one option sold on Amazon, noting the raspberry lemon-flavored gummies use prebiotic chicory root fiber and are marketed for "digestive health, regularity, and overall gut health." The outlet reported that more than 50,000 shoppers bought a bottle in the past month, and quoted one user describing relief from constipation tied to GLP-1 medication use: "Let me paint the picture: I'm on a GLP-1," the user said. "Everything slowed down — and I do mean everything. I got constipated once and swore on everything holy it was never happening again, so I grabbed these fiber gummies."

That testimonial speaks to digestive relief, not arthritis outcomes specifically, underscoring that the joint-pain benefit described by the Nottingham researchers is a separate, newer claim layered on top of fiber's established digestive reputation.

Does this mean fiber supplements treat arthritis?

No single trial reported secondhand through a shopping column establishes that. The Post's article presents the Nottingham findings as a study result — real, but not yet the basis for a treatment recommendation. Readers managing osteoarthritis pain through medication, physical therapy or injections should treat the fiber-GLP-1 link as an area of active research rather than a replacement for clinical care, since the source material offers no dosage guidance, trial duration, or peer-reviewed publication details beyond what the Post summarized.

What to watch next

• Whether the University of Nottingham publishes full trial data, including sample size, dosage and duration, beyond the summary reported by the Post.
• Whether GLP-1's link to pain regulation gets tested in larger, independent arthritis cohorts.
• Whether fiber supplement marketing shifts to emphasize joint health alongside digestive claims, given the commercial incentive already visible in Amazon sales volume cited by the Post.
• Whether rheumatologists or pain specialists comment publicly on the finding, since the current coverage does not include an independent clinical voice outside the study itself.

For now, the claim rests on one trial as described in consumer press, with a hormone-based explanation that is plausible but unproven at scale. Anyone considering fiber supplementation for joint pain should raise the Nottingham findings with a physician rather than treat a gummy bottle as a substitute for arthritis management.

mindfulAI Keyboard — An iPhone keyboard that rewrites a draft in a tone you pick. Four free AI actions a day.